Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generation of Epoetin Positive Samples
NCT02920372Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Nov 2016
- Primary completion
- Jan 2017
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 1, open-label, single-arm trial of epoetin alfa, sponsored by Parc de Salut Mar. Primary endpoint: Blood and urine concentrations of Epoetin alfa. Started Nov 2016; status: completed.
02
Drugs
epoetin alfa
Beyond the preview
Go deeper on NCT02920372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920372.